Mark-specific hazard ratio model with multivariate continuous marks: an application to vaccine efficacy
From MaRDI portal
Publication:77966
DOI10.1111/BIOM.12016zbMATH Open1274.62801OpenAlexW1907075229WikidataQ41991287 ScholiaQ41991287MaRDI QIDQ77966FDOQ77966
Publication date: 19 February 2013
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: http://europepmc.org/articles/pmc3940058
Recommendations
- Mark-specific hazard ratio model with missing multivariate marks
- Proportional hazards models with continuous marks
- The 2-sample problem for failure rates depending on a continuous mark: an application to vaccine efficacy
- Estimation of stratified mark-specific proportional hazards models with missing marks
- Goodness-of-fit test of the stratified mark-specific proportional hazards model with continuous mark
competing risksCox regression modeldensity ratio modelfailure time datagenetic datamark variablemark-specific vaccine efficacy
Cites Work
- Proportional hazards models with continuous marks
- Large sample theory of maximum likelihood estimates in semiparametric biased sampling models.
- Improving the efficiency of the log-rank test using auxiliary covariates
- The 2-sample problem for failure rates depending on a continuous mark: an application to vaccine efficacy
- A Bootstrap Revival of Some Nonparametric Distance Tests
- The Analysis of Failure Times in the Presence of Competing Risks
- Inferences for case-control and semiparametric two-sample density ratio models
- Nonparametric estimation of the joint distribution of survival time and mark variables
- Maximum likelihood estimation in semiparametric selection bias models with application to AIDS vaccine trials
- Proportional hazards tests and diagnostics based on weighted residuals
- A goodness-of-fit test for logistic regression models based on case-control data
- An improved Bonferroni procedure for multiple tests of significance
Cited In (9)
- Predicting overall vaccine efficacy in a new setting by re-calibrating baseline covariate and intermediate response endpoint effect modifiers of type-specific vaccine efficacy
- The 2-sample problem for failure rates depending on a continuous mark: an application to vaccine efficacy
- Leaky vaccines protect highly exposed recipients at a lower rate: implications for vaccine efficacy estimation and sieve analysis
- Failure time analysis of HIV vaccine effects on viral load and antiretroviral therapy initiation
- Estimation of vaccine efficacy for variants that emerge after the placebo group is vaccinated
- Mark-specific hazard ratio model with missing multivariate marks
- sievePH
- Statistical Methods for Assessing Differential Vaccine Protection Against Human Immunodeficiency Virus Types
- A unified evaluation of differential vaccine efficacy
This page was built for publication: Mark-specific hazard ratio model with multivariate continuous marks: an application to vaccine efficacy
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q77966)